CONTACT
FREQUENTLY ASKED QUESTIONS
- Is Cubic Health a benefits consulting firm?
- Do you work directly with employers or in conjunction with their advisors?
- What size of plan sponsors do you work with?
- We're a small company with only about 50 employees. Can these kinds of analyses and reports be provided for groups this small?
- How are you able to provide such specific analyses with plan members' personal information?
- How long does it take you to complete your analyses from the time a proposal is accepted?
-
Is Cubic Health a benefits consulting firm?
No. Cubic Health is an independent drug plan management company founded by practicing pharmacists with combined experience in benefits consulting, drug plan management, and clinical, community and industrial pharmacy practice.
We diagnose utilization and cost pressures, measure and optimize current plan performance, model future spending and alternative plan designs, calculate the overall burden of illness, measure the return on investment related to cost management and workplace wellness strategies, and implement solutions to help our clients achieve their benefits goals. - Do you work directly with employers or in conjunction with their advisors?
Both. In some cases, we work directly with the plan sponsor and their team of in-house benefits specialists and HR professionals. In other situations, we are brought in to partner with the benefits consultants who have been working with the plan sponsor and provide our focused expertise to supplement the consulting services already being provided.
-
What size of plan sponsors do you typically work with?
We work with the whole spectrum of employers across Canada, from the higher-level PDPRs for groups with only 40-50 lives operating in one local area to the comprehensive PPRs for national employers operating with tens of thousands of employees in multiple divisions and jurisdictions.
We have products and services available for groups of all sizes based on the data available for each particular group. -
We're a small company with only about 50 lives covered in our drug plan. Can these kinds of analyses and reports be provided for groups this small?
The best report available for a group this size is the Prescription Drug Plan Review™, which is based on our expert review of the aggregate level breakdowns included in the renewal reports from the insurance carriers and pharmacy benefit managers.
As a policy at Cubic Health, we do not obtain transactional-level claims data for groups with less than 100 lives due to privacy concerns and a limited ability to provide detailed metrics and breakdowns based on transactional data without potentially compromising the confidentiality of individual plan members. As such, those analysis and reports that require the use of the transactional claims data (e.g. Plan Performance Review™, Population Health Analysis, etc.) can only be completed for groups with 100 - How are you able to provide such specific analyses with plan members' personal information?
We hold confidentiality and the principles and regulations in the Personal Information Protection and Electronic Documents Act (PIPEDA) in the highest regard with the work we complete for our clients. The transactional claims data we request from the insurance carriers and pharmacy benefit managers includes only the minimum number of demographic fields required to distinguish claims from one claimant versus another, has the plan members' certificate numbers encrypted, and contains no personally identifiable information (e.g. first name, last name).
Furthermore, while we do provide an array of metrics based on aggregate claimant counts (e.g. the incidence of diabetes within a given plan or among the employees only subgroup), we never report down to an individual claimant level. - How long does it take you to complete your analyses from the time a proposal is accepted?
While the time required to complete our reports varies based on the type and scope of report requested, generally speaking, we strive to complete reviews of carrier-based renewal reports such as the Prescription Drug Plan Review™ within 7 business days of receipt of those renewal reports and to complete our more comprehensive analyses based on transactional claims data (e.g. Plan Performance Review™, Population Health Analysis, etc.) within 3-4 weeks of receipt of the claims data.